Northwestern Mutual Wealth Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $610K | Buy |
|
|||||
|
2025
Q2 | $359K | Buy |
|
|||||
|
2025
Q1 | $234K | Buy |
|
|||||
|
2024
Q4 | $154K | Sell |
|
|||||
|
2024
Q3 | $219K | Buy |
|
|||||
|
2024
Q2 | $249K | Buy |
|
|||||
|
2024
Q1 | $300K | Buy |
|
|||||
|
2023
Q4 | $150K | Buy |
|
|||||
|
2023
Q3 | $104K | Buy |
|
|||||
|
2023
Q2 | $125K | Buy |
|
|||||
|
2023
Q1 | $84.4K | Buy |
|
|||||
|
2022
Q4 | $55.4K | Sell |
|
|||||
|
2022
Q3 | $146K | Buy |
|
|||||
|
2022
Q2 | $56K | Buy |
|
|||||
|
2022
Q1 | $31K | Sell |
|
|||||
|
2021
Q4 | $59K | Hold |
|
|||||
|
2021
Q3 | $87K | Sell |
|
|||||
|
2021
Q2 | $139K | Buy |
|
|||||
|
2021
Q1 | $40K | Buy |
|
|||||
|
2020
Q4 | $8K | Sell |
|
|||||
|
2020
Q3 | $5K | Buy |
|